InsiderClue
Insiders · Profile

Giraudo Bryan

Director at Protagonist Therapeutics · COO/CFO at Gossamer Bio. Filing since 16 May 2017. CIK 0001740847

PTGX Protagonist Therapeutics, Inc Director · 6 trades GOSS Gossamer Bio, Inc. COO/CFO · 13 trades
Company
Date
Role
Action
Shares
Amount
Of holding
PTGX Protagonist Therapeutics, Inc
8 May 2026
Director
Sold at will
6,000
$600.00K
100%
PTGX Protagonist Therapeutics, Inc
8 May 2026
Director
Sold at will
5,130
$513.00K
28.8%
PTGX Protagonist Therapeutics, Inc
7 May 2026
Director
Sold at will
36,000
$3.61M
56.4%
PTGX Protagonist Therapeutics, Inc
7 May 2026
Director
Sold at will
12,000
$1.20M
66.7%
GOSS Gossamer Bio, Inc.
18 Jun 2024
COO/CFO
Bought
100,000
$59.11K
26.3%
GOSS Gossamer Bio, Inc.
27 Mar 2024
COO/CFO
Sold at will
6,430
$7.43K
6.5%
GOSS Gossamer Bio, Inc.
13 Nov 2023
COO/CFO
Bought
200,000
$112.88K
111%
GOSS Gossamer Bio, Inc.
4 Apr 2023
COO/CFO
Bought
55,000
$56.09K
77.5%
GOSS Gossamer Bio, Inc.
20 Mar 2023
COO/CFO
Bought
50,000
$48.44K
238%
GOSS Gossamer Bio, Inc.
15 Jul 2022
COO/CFO
Bought
13,869
$100.00K
195%
GOSS Gossamer Bio, Inc.
23 Mar 2022
COO/CFO
Sold, plan not stated
10,722
$95.59K
9.8%
GOSS Gossamer Bio, Inc.
23 Mar 2021
Chief Financial Officer
Sold, plan not stated
5,490
$52.05K
4.8%
GOSS Gossamer Bio, Inc.
14 Oct 2020
Chief Financial Officer
Bought
3,000
$30.04K
72.8%
GOSS Gossamer Bio, Inc.
23 Jun 2020
Chief Financial Officer
Bought
2,000
$25.92K
94.3%
PTGX Protagonist Therapeutics, Inc
3 Dec 2019
Director
Bought
8,000
$45.62K
opened
GOSS Gossamer Bio, Inc.
26 Sep 2019
Chief Financial Officer
Bought
1,121
$18.81K
112%
GOSS Gossamer Bio, Inc.
30 May 2019
Chief Financial Officer
Bought
1,000
$18.70K
opened
GOSS Gossamer Bio, Inc.
12 Feb 2019
Chief Financial Officer
Bought
6,000
$96.00K
33.6%
PTGX Protagonist Therapeutics, Inc
16 May 2017
Director
Bought
10,000
$64.57K
opened
19 decisions on file.